Advertisement
Screener

GLAUKOS Corp (GKOS) Material Contracts

GLAUKOS Corp Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2025-05-01: Form 10-Q; Exhibit 10.1; Description Directors’ Compensation Policy adopted March 13, 2025.
  • 2024-12-03: Form 8-K; Exhibit 10.1; Description Form of Capped Call Unwind Agreement, dated as of December 2, 2024, by and between Glaukos Corporation and the applicable call option counterparty.
  • 2024-06-05: Form 8-K; Exhibit 10.1; Description Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan.
  • 2024-05-03: Form 10-Q; Exhibit 10.1; Description Directors’ Compensation Policy adopted March 14, 2024.
FiledFormExhibitDescription
2025-05-0110-Q10.1Directors’ Compensation Policy adopted March 13, 2025
2024-12-038-K10.1Form of Capped Call Unwind Agreement, dated as of December 2, 2024, by and between Glaukos Corporation and the applicable call option counterparty
2024-06-058-K10.1Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan
2024-05-0310-Q10.1Directors’ Compensation Policy adopted March 14, 2024
2024-02-2310-K10.23Third Amendment to Lease dated as of January 25, 2024 between the Registrant and 229 Avenida, LLC.
2023-02-2410-K10.19Directors’ Compensation Policy
2022-05-0510-Q10.2Tomas Navratil Executive Severance and Change in Control Agreement dated April 1, 2022
2022-05-0510-Q10.1Alex R. Thurman Executive Severance and Change in Control Agreement dated April 1, 2022
2022-02-2810-K10.22Directors’ Compensation Policy
2021-08-0510-Q10.1Form of Director and Executive Officer Indemnification Agreement
2020-08-0710-Q10.6Second Amendment to Office Building Lease dated as of May 20, 2020, between CIP 2014 SG Aliso Owner, LLC and Glaukos Corporation
2020-08-0710-Q10.5First Amendment to Office Building Lease dated as of December 12, 2018 between CIP 2014/SG Aliso Owner, LLC and Glaukos Corporation
2020-08-0710-Q10.4Second Amendment to Lease dated as of July 2, 2020 between 229 Avenida Fabricante, LLC and Glaukos Corporation
2020-08-0710-Q10.3First Amendment to Lease dated as of December 21, 2018 between 229 Avenida Fabricante, LLC and Glaukos Corporation
2020-06-128-K10.1Form of Capped Call Confirmation.
2020-05-0710-Q10.2Directors’ Compensation Policy
2020-03-0210-K10.25Directors’ Compensation Policy
2020-03-0210-K10.15Form of Notice of Grant of Performance-Based Equity Award under the 2015 Omnibus Incentive Compensation Plan
2019-08-088-K10.1Form of Voting Agreement
2019-02-2810-K10.27Office Building Lease dated as of November 14, 2018, by and between the Registrant and CIP 2014/SG, Aliso Owner LLC.
2018-08-0610-Q10.1Form of Notice of Grant of Restricted Stock Units and Restricted Stock Unit Agreement under the 2015 Omnibus Incentive Compensation Plan (Bonus Election)
2018-05-0910-Q10.1Form of Notice of Non-Statutory Stock Option Grant and Stock Option Agreement under the 2015 Omnibus Incentive Compensation Plan
2018-02-2810-K10.22Form of Director Notice of Grant of Restricted Stock Units and Restricted Stock Unit Agreement under the 2015 Omnibus Incentive Compensation Plan.
2018-02-2810-K10.21Directors’ Compensation Policy
2017-11-078-K10.3Joseph E. Gilliam Executive Severance and Change in Control Agreement dated November 3, 2017
2017-11-078-K10.2Chris M. Calcaterra Executive Severance and Change in Control Agreement dated November 3, 2017
2017-11-078-K10.1Thomas W. Burns Executive Severance and Change in Control Agreement dated November 3, 2017
2017-08-0710-Q10.1Form of Notice of Grant of Restricted Stock Units and Restricted Stock Unit Agreement under the 2015 Omnibus Incentive Compensation Plan
2017-05-058-K10.1Joseph E. Gilliam Executive Severance and Change in Control Agreement dated May 5, 2017.
2017-04-128-K10.1First Amendment to Amended and Restated Patent License Agreement dated as of April 12, 2017 by and between Glaukos Corporation and DOSE Medical Corporation.
2017-03-1510-K10.20The Executive Nonqualified Excess Plan and the Executive Nonqualified Excess Plan Adoption Agreement.
2016-03-1510-K10.23Third Amendment to Lease (regarding Suites 103, 104 and 105), dated as of November 23, 2015, by and between the Registrant and Laguna Cabot Road Business Park, LP.
2015-06-308-K10.2Amended and Restated Transition Services Agreement dated as of June 30, 2015 by and between Glaukos Corporation and DOSE Medical Corporation
2015-06-308-K10.1Amended and Restated Patent License Agreement dated as of June 30, 2015 by and between Glaukos Corporation and DOSE Medical Corporation

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSULET CORP (PODD)United States$9.420B28.12
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Penumbra Inc (PEN)United States$12.596B77.33
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85